Inhibition of pro-apoptotic UPR pathways PERK/CHOP and IRE1/JNK protects differentiated SH-SY5Y cells against rotenone-induced toxicity
Natalia Siwecka(Medical University of Lodz), Ireneusz Majsterek(Medical University of Lodz)
Cited by 0
Related Papers
The Potential Role of Small-Molecule PERK Inhibitor LDN-0060609 in Primary Open-Angle Glaucoma Treatment
|International Journal of Molecular Sciences|2021|14
IRE1/JNK Is the Leading UPR Pathway in 6-OHDA-Induced Degeneration of Differentiated SH-SY5Y Cells
|International Journal of Molecular Sciences|2024|9
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes
|International Journal of Molecular Sciences|2024|3
Combination of alpha-synuclein aggregation inhibitor anle138b and ER stress inhibitor AMG PERK 44 increases neuroprotection in Parkinson’s disease organoid model
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0